Intravitreal Dexamethasone Implant for Patients With Central Retinal Vein Occlusion: Four-Year Outcomes in a Real-World Study. [PDF]
Gkiala A +7 more
europepmc +1 more source
Outcomes of intravitreal dexamethasone implant (Ozurdex®) in patients with post-surgical macular edema - a real-world scenario. [PDF]
de Oliveira Júnior EO +3 more
europepmc +1 more source
Intravitreal dexamethasone implant (Ozurdex®) findings over time: ultrasound and ultra-widefield fundus photography. [PDF]
Pellegrini GABP, Bordon AF, Allemann N.
europepmc +1 more source
Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy? [PDF]
Çakmak S +7 more
europepmc +1 more source
Efficacy of Intravitreal Dexamethasone Implant (Ozurdex<sup>®</sup>) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. [PDF]
Stavrakas P +7 more
europepmc +1 more source
Comment on “Intravitreal dexamethasone implants for diabetic macular edema”
Dan Călugăru +2 more
openaire +3 more sources
Intravitreal Dexamethasone Implant for the Management of Choroidal Neovascular Membrane in Pregnancy. [PDF]
Mehdi I.
europepmc +1 more source
Use of a multifocal electroretinogram to evaluate the therapeutic effect of a single intravitreal dexamethasone implant, Ozurdex<sup>®</sup>, for refractory diabetic macular oedema. [PDF]
Mohammed ARA +3 more
europepmc +1 more source
Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study. [PDF]
Turgut F +11 more
europepmc +1 more source
Assessment the real-world safety of intravitreal dexamethasone implant (Ozurdex): novel insights from a comprehensive pharmacovigilance analysis utilizing the FAERS database. [PDF]
Zhao CF, Lan L, Shi XY, Li J, Fan S.
europepmc +1 more source

